Amneal Pharmaceuticals Inc.
AMRX | NASDAQ
$19.20
-$0.96 (-4.76%)
Sep 22, 2026, 1:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 127.64M | 197.66M | 310.87M | 201.25M | 81.19M | 59.19M | 110.55M | 74.01M | 43.77M | 48.46M | 91.54M | 86.93M | 109.28M | 144.67M | 25.98M | 87.34M | 91.98M | 210.48M | 247.79M | 302.66M | 278.31M | 452.1M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 1.87M | n/a | 3.45M | n/a | 2.2M | 5.12M | 3.36M | 3.31M | 1.82M | 2.17M | 1.69M | 1.6M | 1.17M | 2.11M | 1.3M | n/a |
Long-Term Investments | n/a | 12.73M | 7.82M | n/a | 18.92M | 26.39M | 35.92M | 17.94M | 52.46M | 52.63M | 37.09M | 74.34M | 79.63M | 71.32M | 85.59M | 88.86M | 56.22M | 42.15M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 132.81M | 42.15M | 49.98M | 39.46M | 25.93M | 19.03M | 24.21M | 18.34M | 24.57M | 21.12M | 18.43M | 14.71M | 13.61M | 15.11M | 17.63M | 19.4M | 23.62M | 21.79M | 20.61M | 19.53M | 19.22M | 19.56M |
Receivables | 1.02B | 902.65M | 939.87M | 924.14M | 849.27M | 800.29M | 775.73M | 786.23M | 803.38M | 704.05M | 645.66M | 690.95M | 674.74M | 545.76M | 741.79M | 628.74M | 688.85M | 538.31M | 662.58M | 627.95M | 652.02M | 530.6M |
Inventory | 677.95M | 641.62M | 606.3M | 614.5M | 608.97M | 601.43M | 612.45M | 596.36M | 575.62M | 570.65M | 581.38M | 576.47M | 550.56M | 529.04M | 530.74M | 543.86M | 533.03M | 512.24M | 489.39M | 520.25M | 523.39M | 497.01M |
Other Current Assets | 8.64M | 4.17M | 4.44M | 34.73M | 3.74M | 9.02M | 40.7M | 4.34M | 2.41M | 5.1M | 7.57M | 48.89M | 44.3M | 44.35M | 64.37M | 112.82M | 192.46M | 77.86M | 74.11M | 75.8M | 71.1M | 4.82M |
Total Current Assets | 1.95B | 1.8B | 1.91B | 1.84B | 1.58B | 1.51B | 1.59B | 1.51B | 1.49B | 1.38B | 1.38B | 1.46B | 1.42B | 1.31B | 1.41B | 1.42B | 1.55B | 1.39B | 1.52B | 1.57B | 1.56B | 1.56B |
Property-Plant & Equipment | 515.86M | 558.76M | 550.33M | 538.06M | 546.29M | 522.75M | 523.69M | 532.9M | 528.94M | 544.79M | 550.14M | 560.8M | 571.28M | 578.38M | 589.36M | 587.44M | 602.77M | 622.64M | 639M | 585.41M | 597.95M | 595.14M |
Goodwill & Intangibles | 1.18B | 1.13B | 1.16B | 1.18B | 1.25B | 1.29B | 1.33B | 1.38B | 1.42B | 1.46B | 1.49B | 1.58B | 1.61B | 1.65B | 1.69B | 1.76B | 1.81B | 1.81B | 1.76B | 1.8B | 1.84B | 1.79B |
Total Long-Term Assets | 1.83B | 1.74B | 1.77B | 1.76B | 1.84B | 1.85B | 1.91B | 1.95B | 2.02B | 2.08B | 2.09B | 2.23B | 2.28B | 2.32B | 2.39B | 2.45B | 2.49B | 2.5B | 2.42B | 2.4B | 2.46B | 2.4B |
Total Assets | 3.78B | 3.54B | 3.68B | 3.6B | 3.42B | 3.37B | 3.5B | 3.46B | 3.51B | 3.46B | 3.47B | 3.69B | 3.7B | 3.63B | 3.8B | 3.87B | 4.04B | 3.89B | 3.94B | 3.97B | 4.02B | 3.96B |
Account Payables | 721.21M | 227.68M | 254.67M | 266.36M | 666.82M | 192.53M | 259.84M | 235M | 199.58M | 175.33M | 143.57M | 177.4M | 139.53M | 136.92M | 166.84M | 533.44M | 563.83M | 541.8M | 132.87M | 591.21M | 597.93M | 581.42M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 400.27M | 398.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 105.96M | 6.2M | 21.58M | 7.2M | 321.18M | 321.79M | 324.21M | 364.69M | 435.52M | 212.66M | 213.13M | 106.53M | 150.41M | 129.97M | 89.96M | 89.94M | 114.92M | 30.52M | 30.61M | 30.47M | 30.46M | 29.82M |
Other Current Liabilities | 22.07M | 64.82M | 525.5M | 104.5M | 104.91M | 85.1M | 222.36M | 198.08M | 194.76M | -14.68M | 3.91M | 220.01M | 240.77M | 241.77M | 263.11M | 177.48M | 277.55M | 13.39M | 277.77M | 29.97M | 30.23M | 12M |
Total Current Liabilities | 883.19M | 728.05M | 881.63M | 862.11M | 1.11B | 1.08B | 1.13B | 1.1B | 1.11B | 834.39M | 846.6M | 760.6M | 777.35M | 703.71M | 752.8M | 818M | 993.06M | 602.04M | 677.24M | 667.34M | 672.86M | 636.78M |
Long-Term Debt | 2.56B | 2.57B | 2.61B | 2.57B | 2.15B | 2.15B | 2.16B | 2.17B | 2.18B | 2.42B | 2.43B | 2.58B | 2.59B | 2.6B | 2.63B | 2.65B | 2.66B | 2.71B | 2.73B | 2.76B | 2.79B | 2.77B |
Other Long-Term Liabilities | 105.84M | 168.47M | 75.79M | 183.47M | 115.9M | 106.86M | 163.33M | 135.81M | 126.14M | 121.45M | 41.77M | 52.92M | 48.41M | 52.66M | 97.12M | 88.55M | 89.87M | 43.24M | 37.05M | 40.65M | 39.54M | 78.93M |
Total Long-Term Liabilities | 2.78B | 2.86B | 2.79B | 2.85B | 2.36B | 2.35B | 2.42B | 2.4B | 2.4B | 2.64B | 2.56B | 2.74B | 2.74B | 2.76B | 2.84B | 2.84B | 2.86B | 2.86B | 2.88B | 2.91B | 2.95B | 2.96B |
Total Liabilities | 3.74B | 3.59B | 3.67B | 3.71B | 3.47B | 3.42B | 3.55B | 3.49B | 3.51B | 3.47B | 3.41B | 3.5B | 3.52B | 3.46B | 3.59B | 3.66B | 3.85B | 3.47B | 3.56B | 3.58B | 3.62B | 3.59B |
Total Debt | 2.79B | 2.7B | 2.74B | 2.69B | 2.58B | 2.58B | 2.59B | 2.64B | 2.73B | 2.75B | 2.75B | 2.8B | 2.86B | 2.85B | 2.85B | 2.86B | 2.9B | 2.87B | 2.89B | 2.91B | 2.95B | 2.92B |
Book Value | 33.07M | -45.97M | 5.96M | -109.96M | -46.73M | -59.39M | -44.54M | -33.68M | -4.07M | -16.61M | 61.3M | 191.38M | 182.87M | 162.2M | 208.93M | 216.66M | 190.88M | 423.83M | 383.88M | 398.43M | 404.38M | 366.71M |
Book Value Per Share | 0.10 | -0.14 | 0.02 | -0.34 | -0.14 | -0.18 | -0.14 | -0.11 | -0.01 | -0.05 | 0.25 | 1.20 | 1.18 | 1.07 | 1.38 | 1.43 | 1.26 | 2.83 | 2.57 | 2.67 | 2.66 | 2.42 |
Common Stock | n/a | 3.19M | 3.15M | 3.14M | 3.14M | 3.13M | 3.1M | 3.1M | 3.1M | 3.09M | 3.07M | 3.06M | 3.06M | 3.05M | 3.04M | 3.04M | 3.03M | 3.03M | 3.01M | 3.01M | 3.01M | 3.01M |
Retained Earnings | n/a | -472.75M | -535.01M | -570.08M | -572.45M | -594.87M | -607.06M | -575.98M | -575.83M | -581.82M | -490.18M | -391.53M | -401.21M | -413.13M | -406.18M | -401.85M | -399.16M | -278.35M | -276.2M | -269.82M | -265.58M | -280.12M |
Comprehensive Income | n/a | -112.15M | -110.73M | -105.88M | -97.43M | -85.74M | -65.51M | -73.78M | -30.44M | -23.71M | -32.35M | 3.87M | 8.08M | 3.76M | 9.94M | 12.54M | 868K | -349K | -24.83M | -33.23M | -33.98M | -34.36M |
Shareholders Equity | 33.02M | -45.41M | -70.79M | -109.46M | -112.53M | -131.67M | -109.27M | -93.43M | -57.47M | -63.72M | 19.78M | 330.86M | 318.17M | 294.41M | 298.42M | 297.47M | 280.33M | 391.13M | 360.34M | 350.51M | 346.11M | 323.02M |
Total Investments | n/a | 12.73M | 7.82M | n/a | 18.92M | 26.39M | 37.79M | 17.94M | 55.91M | 52.63M | 39.29M | 79.46M | 82.99M | 74.62M | 87.41M | 91.03M | 57.92M | 43.75M | 1.17M | 2.11M | 1.3M | n/a |
Add to Watchlist
Select watchlists to add or remove AMRX